Loading Events

Register for Event

7:30 – 8:40 am

Registration, networking, visit vendor exhibits

8:40 – 8:45 am


8:45 – 9:20 am

Novel In Vitro Hepatic and Enteric Technologies for the Evaluation of Human Drug Properties
Albert Li (In Vitro ADMET Labs)

9:20 – 9:55 am

Assessment of Hepatitis Viral Infections and Drug Clearance in Hµrel™ Hepatocyte Co-culture Model
Cheul H. Cho (Hµrel)

9:55 – 10:25 am

Coffee break, networking, visit vendor exhibits

10:25 – 11:00 am

One More Step Closer to FDA Compliance: New Transporter Probe Substrates and Assay Calibration
Krisztina Herédi-Szabo (Solvo)

11:00 – 11:35 am

Enzyme- and Transporter-based DDI Risk Assessment from Early Drug Development to Patient Stratification
Pooja Jain, Elsevier; Veronique Michaud and Jacques Turgeon (Tabula Rasa Healthcare)
Slides available upon request, contact Pooja Jain at pooja.jain@elsevier.com

11:35 – 12:55 pm

Lunch, networking, visit vendor exhibits

1:00 – 1:35 pm

Application of LC-HRMS in Pharmacokinetics and Metabolism of Oligonucleotides
Helen Shen (QPS)

1:35 – 2:10 pm

Bioanalytical Strategy to Support CAR-T Therapies: Where Are the Challenges?
Corinna Fiorotti (BioAgilytix)

2:10 – 2:30 pm

Coffee break, networking, visit vendor exhibits

2:30 – 3:05 pm

Observed vs. Predicted Effects of Protein Binding: Improving In Vivo Predictions of Hepatic Clearance, Intracellular Concentration, and IC50 Values
Ken Brouwer (BioIVT)

3:05 – 3:40 pm

In Vitro Dissolution Absorption System (IDAS): Simultaneous Dissolution and Permeation Evaluation
Chris Bode (Absorption Systems)

Share This Post, Choose Your Platform!